Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2015 | RBMY, a novel inhibitor of glycogen synthase kinase 3beta, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma. | Chua, HH; Tsuei, DJ; Lee, PH; Jeng, YM; Lu, J; Wu, JF; Su, DS; Chen, YH; Chien, CS; Kao, PC; Lee, CN; Hu, RH; Ni, YH; Chang, MH | Hepatology 62(5), 1480-1496 | | | |
2003 | Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins | Lu, J; Chua, HH; Chen, SY; Chen, JY; Tsai, CH | Cancer Res 63, 256-262 | | | |
2000 | Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta | Lu, J; Chen, SY; Chua, HH; Liu, YS; Huang, YT; Chang, Y; Chen, JY; Sheen, TS; Tsai, CH | J Virol 74, 7391-7399 | | | |